TTP disease course is independent of myeloma treatment and response

American Journal of Hematology

Volumn 85, Issue 4, 2010, Pages 304-306

  Hofmeister, Craig C ^a   Jin, Ming ^b   Cataland, Spero R ^a   Benson, Don M ^a   Wu, Haifeng ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CALCIUM; CREATININE; CYCLOSPORIN; DEXAMETHASONE; FRESH FROZEN PLASMA; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; LENALIDOMIDE; MELPHALAN; THALIDOMIDE; TROPONIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ABDOMINAL PAIN; ADULT; BONE MARROW BIOPSY; CALCIUM BLOOD LEVEL; CASE REPORT; COMPRESSION FRACTURE; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG RESPONSE; FEMALE; GAMMOPATHY; HEART INFARCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCALCEMIA; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; LOW BACK PAIN; MALE; MENTAL DETERIORATION; MICROTHROMBUS; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PERIPHERAL NEUROPATHY; PETECHIA; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; SYNCOPE; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 77950438425     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21646     Document Type: Letter

References (11)

1. Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467-1473. (Pubitemid 44264086)
2. Cataland SR, Jin M, Ferketich AK, et al. An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Br J Haematol 2007;136:146-149.
3. Cataland SR, Jin M, Lin S, et al. Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: Long-term follow-up with serial analysis of ADAMTS13 activity. Br J Haematol 2007;139:486-493. (Pubitemid 47512185)
4. Jin M, Cataland S, Bissell M, Wu HM. A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry. J Thromb Haemost 2006;4:333-338.
5. Dong JF, Moake JL, Nolasco L, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002;100:4033-4039. (Pubitemid 35396870)
6. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-1594. (Pubitemid 28536133)
7. van der Plas RM, Schiphorst ME, Huizinga EG, et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood 1999;93:3798-3802.
8. Sarode R, McFarland JG, Flomenberg N, et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1995;16:271-275.
9. Kornacker M, Luft T, Ho AD, Schaefer HJ. Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - Report of three cases. Eur J Haematol 2005;74:250-253. (Pubitemid 40278495)
10. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005;435:620-627. (Pubitemid 40825502)
11. Burt RK, Loh Y, Cohen B, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: A phase I/II study. Lancet Neurol 2009;8:244-253.